Interrelations between polymorphism of a gene of a methylenetetrahydrofolatreductase with level of Homocystein in patients with 2 type of diabetes

Authors

  • A.R. Alina
  • L.G. Turgunova
  • Ye.M. Laryushina
  • N.V. Vasilyeva
  • D.T. Amirkhanova

DOI:

https://doi.org/10.31489/2015bmg2/56-63

Keywords:

diabetes mellitus type 2, coronary heart illness, homocysteine, methylenetetrahydrofolate

Abstract

Purpose of the research — to study the frequency of occurrence of polymorphism ST gene methylenetetrahydrofolate patients with diabetes mellitus type 2 and its correlation with homocysteine levels and the devel-opment of ischemic heart diseases. 118 patients with diabetes mellitus type 2 at the age of 45–60 years were
surveyed. Statistically significant differences were observed frequencies of alleles of T and S, genotype SS between groups of patients with pancreatic diabetes type 2 with ischemic heart disease and tran- sferred myocardial infarction and healthy persons. It was found that the allele T 677 gene, methylentetrahydrofolat-reductase associated with an increased risk of myocardial infarction in patients with diabetes mellitus type 2 (OR=1,879, p=0,029). The combination of genotype T677 gene methylenetetrahydrofolatereductase with hyperhomocysteinemia in 2 type diabetic patients with coronary heart disease is related with other risk factors
for cardiovascular diseases and can have a significant impact on the course of ischemic heart disease.

Downloads

Published

2015-06-30

Issue

Section

Articles